Skip to main content
TRIGYN AWARDED DATA CAPTURE PROJECT BY UN SPECIALIZED AGENCY AT NIGERIAN REGISTER OF TRADEMARKS, PATENTS AND DESIGNS

TRIGYN AWARDED DATA CAPTURE PROJECT BY UN SPECIALIZED AGENCY AT NIGERIAN REGISTER OF TRADEMARKS, PATENTS AND DESIGNS

Trigyn Technologies Inc., a wholly-owned subsidiary of Trigyn Technologies Limited has launched the Data Capture project awarded by one of the United Nations Specialized Agencies at Nigerian Register of Trademarks, Patents and Designs for digitizing the IP registrations, applications, etc. The objective of project is to populate a database containing textual bibliographic information, digitized images and workflow information for the Trademarks files kept by the Nigerian office.

Trigyn has been a trusted and reliable IT Services provider to the United Nations Specialized Agency for many years. This contract will enable Trigyn to continue to build on its extensive presence throughout Africa as well as other intergovernmental organizations.

Recent News

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Trigyn Announces AI Innovation and Delivery Center

Trigyn Announces AI Innovation and Delivery Center

Trigyn Announces AI Innovation and Delivery Center

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Technologies Inc. is a wholly owned subsidiary of Trigyn Technologies Ltd. collectively, we are committed to providing transparent and timely information to all of the stakeholders who have put their trust in us.

For any media-related inquiries, we encourage you to use our “Contact Us” form, available by clicking here.

For information about investment-related topics or stock information, please visit our Investors page by clicking here. For Investor or stock related inquiries, please use the contact information specified on the Investors page.

Thank you for your interest in Trigyn.